Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. That said, here are three stocks where Wall Street’s enthusiasm may be misplaced and some other investments worth exploring instead.
Intel (INTC)
Consensus Price Target: $115.78 (26.6% implied return)
Inventor of the x86 processor that powered decades of technological innovation in PCs, data centers, and numerous other markets, Intel (NASDAQ: INTC) is a leading manufacturer of computer processors and graphics chips.
Why Is INTC Risky?
- Sales tumbled by 4.9% annually over the last five years, showing market trends are working against it during this cycle
- Earnings per share decreased by more than its revenue over the last five years, partly because it diluted shareholders
- Cash burn makes us question whether it can achieve sustainable long-term growth
Intel’s stock price of $91.49 implies a valuation ratio of 54.1x forward P/E. To fully understand why you should be careful with INTC, check out our full research report (it’s free).
Sinclair (SBGI)
Consensus Price Target: $17.57 (26.1% implied return)
With over 2,400 hours of local news produced weekly and 640 broadcast channels reaching millions of American homes, Sinclair (NASDAQ: SBGI) operates a network of 185 local television stations across 86 U.S. markets, producing news programming and distributing content from major networks.
Why Do We Avoid SBGI?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 12% annually over the last five years
- Diminishing returns on capital suggest its earlier profit pools are drying up
- High net-debt-to-EBITDA ratio of 7× could force the company to raise capital on unfavorable terms if market conditions deteriorate
Sinclair is trading at $13.93 per share, or 6.8x forward EV-to-EBITDA. If you’re considering SBGI for your portfolio, see our FREE research report to learn more.
DaVita (DVA)
Consensus Price Target: $218.43 (20.8% implied return)
With over 2,600 dialysis centers across the United States and a presence in 13 countries, DaVita (NYSE: DVA) operates a network of dialysis centers providing treatment and care for patients with chronic kidney disease and end-stage kidney disease.
Why Is DVA Not Exciting?
- Flat treatments over the past two years suggest it might have to lower prices to accelerate growth
- Estimated sales growth of 1.7% for the next 12 months implies demand will slow from its two-year trend
- Adjusted operating margin was unchanged over the last two years, suggesting it failed to gain leverage on its fixed costs
At $180.75 per share, DaVita trades at 11.4x forward P/E. Check out our free in-depth research report to learn more about why DVA doesn’t pass our bar.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
